News

Olive O’Driscoll, Clinical Industry Liaison Officer (CILO) at the National Clinical Trials Office.

Olive is a biomedical engineer who trained in the NHS and then moved on to work in the UK and Ireland in medical device clinical research and regulatory affairs both in industry (e.g. Medtronic Cryocath, Crescent Diagnostics) and academia (e.g. University College London). She held senior management positions in medical device and pharmaceutical regulated clinical trials in Ireland, Europe and USA across multiple therapeutic areas including oncology, ENT, diagnostics, cardiovascular and rheumatology.  She founded Irish medical device start-up AventaMed in 2013 and led the company as CEO, raising over €5m in investment and growing the company from prototype/concept stage to commercialisation. This involved conducting multiple clinical investigations (in EU and USA), FDA pre-submission meetings and IDEs in USA, and regulatory approval of the device, which is now commercial in Europe.

She joined NCTO in April 2022 in this Enterprise Ireland funded role and is working with medical device companies and academic entrepreneurs in Ireland to help them navigate the clinical research landscape and supports available.